That is the title of a paper published today in Current Medical Research and Opinion with co-authors Nadine Zawadzki, Moises Marin, Ivana Audhya, Lauren Sedita, Natasha Kulkarni and Alexa Klimchak. The abstract is below. ObjectivesQuantify caregiver risk preferences to inform the “value of hope” for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of…
[Sponsored] Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs. The post The Healthcare Payments Industry Has a Perception Problem appeared first on MedCity News.
This brief summarizes recent and proposed actions by states related to access to state-funded health coverage and other services for immigrants and immigration enforcement activity during the 2025 and 2026 state legislative sessions.
Modern technology with AI at its center is creating unique opportunities to approach healthcare challenges in ways that weren’t possible just a few years back. The post How Technology Is Personalizing Healthcare in 2025 appeared first on MedCity News.
June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health and HCA Healthcare welcomed new executives, and Ascension and Optum Health announced that their CEOs are departing. There were also layoffs at organizations including Providence, UCSF Health and Vanderbilt University Medical Center. The post Healthcare…
Health tech companies made several major funding announcements in June. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in June appeared first on MedCity News.
That is the news out of the UK today. A press release from the United Kingdom government states: A 25% increase in medicine pricing corresponds to 2 changes to the way NICE evaluates medicines; a change to the cost effectiveness thresholds and the introduction of a new value set for judging health states.NICE currently assesses value for money…
Health and Human Services Secretary Robert F. Kennedy Jr. is fielding pressure from the White House to relax his controversial approach to vaccine policies as the midterms near, but his most steadfast supporters are pressing for more aggressive action — like restricting covid-19 vaccines and pesticide use — to carry out the Make America Healthy…
Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex Pharmaceuticals product Trikafta. The biotech has three internally developed programs that hit a target unaddressed by any currently available CF therapies. The post Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline appeared first on…
AIAN individuals experience significant health disparities compared to their White counterparts. People who identified as AIAN alone have shorter life expectancies (70.1 vs 78.4 years at birth), higher rates of chronic diseases, and higher rates of suicide deaths and substance use disorder.